Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
出版年份 2018 全文链接
标题
Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
作者
关键词
Gout, Treatment, Cardiovascular disease, Meta-analysis, Xanthine Oxidase inhibitors
出版物
BMC Cardiovascular Disorders
Volume 18, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-02-07
DOI
10.1186/s12872-018-0757-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Allopurinol as a therapeutic option in cardiovascular disease
- (2017) Osita N Okafor et al. PHARMACOLOGY & THERAPEUTICS
- Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis
- (2017) Tony Zhang et al. RHEUMATOLOGY
- Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution
- (2017) Lisa Stamp et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis
- (2016) Li-hui Qu et al. ANNALS OF MEDICINE
- Allopurinol and the risk of stroke in older adults receiving medicare
- (2016) Jasvinder A. Singh et al. BMC Neurology
- Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials
- (2016) Wei Xin et al. Cardiovascular Therapeutics
- The Impact of Allopurinol on Patients With Acute ST Elevation Myocardial Infarction Undergoing Thrombolytic Therapy
- (2016) Ahmad Separham et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials
- (2016) Gang Deng et al. MEDICAL SCIENCE MONITOR
- Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial
- (2015) Marian Goicoechea et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Xanthine Oxidase Inhibitors in Heart Failure: Where Do We Go From Here?
- (2015) L. Tamariz et al. CIRCULATION
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
- (2015) M. M. Givertz et al. CIRCULATION
- Allopurinol use and risk of non-fatal acute myocardial infarction
- (2015) Francisco J de Abajo et al. HEART
- Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: A randomized controlled study
- (2015) Yuki Tsuruta et al. Hemodialysis International
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- (2015) Tahir Kanji et al. BMC Nephrology
- Effects of Allopurinol on Endothelial Dysfunction: A Meta-Analysis
- (2014) Mehmet Kanbay et al. AMERICAN JOURNAL OF NEPHROLOGY
- Impact of allopurinol on risk of myocardial infarction
- (2014) L Grimaldi-Bensouda et al. ANNALS OF THE RHEUMATIC DISEASES
- Allopurinol initiation and all-cause mortality in the general population
- (2014) Maureen Dubreuil et al. ANNALS OF THE RHEUMATIC DISEASES
- Improving cardiovascular and renal outcomes in gout: what should we target?
- (2014) Pascal Richette et al. Nature Reviews Rheumatology
- Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia
- (2014) L. K. Stamp et al. RHEUMATOLOGY
- Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia
- (2014) T. M. MacDonald et al. BMJ Open
- Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
- (2013) Francisca Sivera et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of Febuxostat and Allopurinol for Hyperuricemia in Cardiac Surgery Patients (NU-FLASH Trial)
- (2013) Akira Sezai et al. CIRCULATION JOURNAL
- Safety profile of anti-gout agents
- (2013) Lisa K. Stamp CURRENT OPINION IN RHEUMATOLOGY
- As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout
- (2013) A.-K. Tausche et al. RHEUMATOLOGY INTERNATIONAL
- Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
- (2012) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Changes in Uric Acid Levels and Allopurinol Use in Chronic Heart Failure: Association With Improved Survival
- (2012) Israel Gotsman et al. JOURNAL OF CARDIAC FAILURE
- Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta-Analysis
- (2012) Vikram Agarwal et al. Journal of Clinical Hypertension
- Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice
- (2012) L. K. Stamp et al. RHEUMATOLOGY
- Meta-analysis of incidence of rare events
- (2012) Peter W Lane STATISTICAL METHODS IN MEDICAL RESEARCH
- Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta-Analysis
- (2011) Peter Higgins et al. Cardiovascular Therapeutics
- Relationship Between Serum Urate and Plasma Oxypurinol in the Management of Gout: Determination of Minimum Plasma Oxypurinol Concentration to Achieve a Target Serum Urate Level
- (2011) L K Stamp et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gout, Allopurinol Use, and Heart Failure Outcomes
- (2010) George Thanassoulis ARCHIVES OF INTERNAL MEDICINE
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
- (2010) M. Goicoechea et al. Clinical Journal of the American Society of Nephrology
- Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone
- (2008) Adrian V. Hernandez et al. AMERICAN HEART JOURNAL
- Impact of Oxypurinol in Patients With Symptomatic Heart Failure
- (2008) Joshua M. Hare et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started